Metaxalone
- Product NDC
- 70934-429
- 11-digit product format
- 709340429
- Labeler code
- 70934
- Product ID
- 70934-429_ad27b2c8-d03c-6193-e053-2a95a90a056d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA208774
- Marketing category
- ANDA
- Marketing start
- 2019-08-13
- Marketing end
- 0000-00-00
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-429-10 | 70934042910 | 10 TABLET in 1 BOTTLE, PLASTIC (70934-429-10) | 10 tablet | 2019-08-13 | 0000-00-00 | No | No | Current |
| 70934-429-30 | 70934042930 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-429-30) | 30 tablet | 2020-02-26 | 0000-00-00 | No | No | Current |